Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
The Ministry of Health and Prevention (MOHAP) in the UAE Approves…
The Launch of AditxtScore™ for COVID-19 by Aditxt, Inc. (NASDAQ: ADTX)…
The FDA Grants Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) Fast Track Designation…
Hong Kong Health Experts Say Adolescents Should Receive One Dose Of…
Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health…
Finance
Sesen Bion (NASDAQ: SESN) Completes Vicineum Commercialization Plans Ahead Of Approval
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Amarin Corporation Plc
Tag: Amarin Corporation Plc
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From...
Gavins Felicity
-
April 23, 2021
0
Amarin Corporation plc (NASDAQ:AMRN) Presents VASCEPA® Clinical Study Findings At The...
Matt Wade
-
February 3, 2021
0
Amarin Corporation plc (NASDAQ:AMRN) Announces Q3 Results As VASCEPA Continues To...
Gavins Felicity
-
November 11, 2020
0
Amarin (NASDAQ:AMRN)Established That VASCEPA® can Reduce Ischemic Events In Individuals That...
Kate Hudson
-
October 28, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) Supported New Data from Clinical Research Evaluating...
Ward Sport
-
September 7, 2020
0
Amarin Corporation Plc (NASDAQ:AMRN) Reports A Growth Of 34% YoY In...
Matt Wade
-
August 24, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) says it is Supporting Investigator-Initiated Trial Evaluating...
Ward Sport
-
August 19, 2020
0
Data from the REDUCE-IT® REVASC Analysis Presented by Amarin Corporation plc....
Gavins Felicity
-
August 14, 2020
0
Amarin Corporation Plc (NASDAQ:AMRN) Reaches Settlement With Apotex Regarding Generic VASCEPA
Kate Hudson
-
June 26, 2020
0
Close
